Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire

scientific article published on 10 September 2018

Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1106904898
P356DOI10.1186/S10194-018-0914-7
P932PMC publication ID6131677
P698PubMed publication ID30203193

P50authorAlberto RaggiQ37830338
Licia GrazziQ42702480
Antonio RussoQ46653000
Domenico D'AmicoQ51846705
Carlo LovatiQ52358451
Matilde LeonardiQ56936660
Piero BarbantiQ57160906
Erika GuastafierroQ57303447
Chiara ScarattiQ59766766
Luca GianiQ84010295
Venusia CovelliQ86075185
Gioacchino TedeschiQ87660234
Giulia PierangeliQ88383689
Giovanna ViticchiQ91681294
Francesco BonoQ104258958
Sabina CevoliQ114447259
Cinzia AuriliaQ114447260
Laura RapisardaQ114447261
P2093author name stringFabio Frediani
Marco Bartolini
Paola Di Fiore
P2860cites workGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Q28083357
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Q28111913
The International Classification of Headache Disorders, 3rd edition (beta version)Q29392338
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 studyQ30966181
Workplace productivity. A review of the impact of migraine and its treatmentQ34219693
The stigma of migraineQ34559119
The global burden of headache: a documentation of headache prevalence and disability worldwideQ34611721
Chronic migraine plus medication overuse headache: two entities or not?Q35522746
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuseQ36234332
A systematic review of the psychosocial difficulties relevant to patients with migraineQ36357101
Cost of medication overuse headache in Italian patients at the time-point of withdrawal: a retrospective study based on real dataQ36376857
Prevalence, burden, and cost of headache disordersQ36479944
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patientsQ36878256
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of lifeQ37176670
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future researchQ37176674
Humanistic and economic burden of nausea and vomiting among migraine sufferersQ37730599
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review.Q37861402
Disability in chronic daily headache: state of the art and future directionsQ37870786
Cost of disorders of the brain in Europe 2010.Q37933664
The cost of headache disorders in Europe: the Eurolight projectQ37963926
Disability and quality of life in headache: where we are now and where we are heading.Q38108474
Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature reviewQ38215466
Quality of life in primary headache disorders: A reviewQ38427435
World Health Organization disability assessment schedule 2.0: An international systematic reviewQ39002028
Validation of a migraine work and productivity loss questionnaire for use in migraine studiesQ39437824
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Q41689462
Cronbach's alphaQ41957253
Migraine: the seventh disablerQ43217625
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuseQ45376934
Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention StudyQ45395151
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraineQ45848975
Assessing the impact of migraine onset on work productivityQ48325470
Migraine is first cause of disability in under 50s: will health politicians now take notice?Q50301000
Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine.Q50550552
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.Q50617460
The migraine work and productivity loss questionnaire: concepts and design.Q51976699
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.Q52674495
Burden of migraine: international perspectives.Q53109838
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).Q53524572
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd editionQ56627246
Multimorbidity in patients with chronic migraine and medication overuse headacheQ60698133
Gender and education inequalities in the cost of medication-overuse headacheQ60698145
The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it?Q60698163
The Migraine Disability Assessment (MIDAS) Questionnaire: Translation and Reliability of the Italian VersionQ61698703
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) scoreQ73016930
The validity and reproducibility of a work productivity and activity impairment instrumentQ74822877
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialQ84582635
Chronic migraine with and without medication overuse: experience in a hospital series of 434 patientsQ87173394
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmigraineQ133823
questionnaireQ747810
P304page(s)85
P577publication date2018-09-10
P1433published inThe journal of headache and pain : official journal of the Italian Society for the Study of HeadachesQ26842211
P1476titleValidation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire
P478volume19

Search more.